Original ReportLow-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Under an Elsevier user license
open archive
Key words
Neuropathic pain
analgesia
cannabis
clinical trial
neuropsychological testing
Cited by (0)
This publication was made possible by Grant Number UL1 RR024146 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Information on NCRR is available at http://www.ncrr.nih.gov/. Information on Re-Engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp.
The authors have no conflicts of interest to report.
Published by Elsevier Inc.